ADI1
Acireductone dioxygenase
Also known as: APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, MTND_HUMAN, SIPL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BV57
- Gene
- ADI1
- Ensembl
- ENSG00000182551
- Chromosome
- 2
- Canonical length
- 179 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
This gene encodes an enzyme that belongs to the aci-reductone dioxygenase family of metal-binding enzymes, which are involved in methionine salvage. This enzyme may regulate mRNA processing in the nucleus, and may carry out different functions depending on its localization. Related pseudogenes have been defined on chromosomes 8 and 20. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]
Canonical amino-acid sequenceUniProt
179 residues, UniProt reviewed canonical sequence.
>Q9BV57|ADI1
1 MVQAWYMDDA PGDPRQPHRP DPGRPVGLEQ LRRLGVLYWK LDADKYENDP ELEKIRRERN
61 YSWMDIITIC KDKLPNYEEK IKMFYEEHLH LDDEIRYILD GSGYFDVRDK EDQWIRIFME
121 KGDMVTLPAG IYHRFTVDEK NYTKAMRLFV GEPVWTAYNR PADHFEARGQ YVKFLAQTALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADI1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 552 nTPM
Expression across tissuesHPA
Tissue
- liver: 552 nTPM
- kidney: 187 nTPM
- heart muscle: 137 nTPM
- blood vessel: 134 nTPM
- skeletal muscle: 119 nTPM
- duodenum: 98 nTPM
Single-cell type
- hepatocytes: 309 nCPM
- megakaryocytes: 74 nCPM
- platelets: 56 nCPM
- thymic myoid cells: 49 nCPM
- salivary ionocytes: 46 nCPM
- hepatic stellate cells: 45 nCPM
Immune cell
- eosinophil: 338 nTPM
- total PBMC: 189 nTPM
- plasmacytoid DC: 187 nTPM
- classical monocyte: 135 nTPM
- myeloid DC: 128 nTPM
- intermediate monocyte: 127 nTPM
Brain region
- choroid plexus: 65 nTPM
- white matter: 45 nTPM
- medulla oblongata: 44 nTPM
- cerebral cortex: 43 nTPM
- pons: 42 nTPM
- basal ganglia: 42 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.69
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- iron ion binding
- nickel cation binding
- oxidoreductase activity
- acireductone dioxygenase (Ni2+-requiring) activity
- acireductone dioxygenase [iron(II)-requiring] activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RmlC-like cupin domain superfamily
- RmlC-like jelly roll fold
- Acireductone dioxygenase ARD family
- Acireductone dioxygenase, eukaryotes
- ARD/ARD' family
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADI1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADI1 as an antibody target. Whether an autoantibody or antibody against ADI1 could matter depends on whether native ADI1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADI1 is annotated at the cell surface, where native ADI1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADI1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...